- Home
- LCNB vs BIOA Comparison
LCNB vs BIOA Comparison
Compare LCNB & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LCNB | BIOA |
|---|---|---|
| Founded | 1877 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 205.5M | 175.7M |
| IPO Year | N/A | 2024 |
Fundamental Metrics
Financial Performance| Metric | LCNB | BIOA |
|---|---|---|
| Price | $15.67 | $9.11 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 20.9K | ★ 227.1K |
| Earning Date | 10-22-2025 | 11-06-2025 |
| Dividend Yield | ★ 5.57% | N/A |
| EPS Growth | ★ 220.73 | N/A |
| EPS | ★ 1.67 | N/A |
| Revenue | ★ $89,312,000.00 | $5,917,000.00 |
| Revenue This Year | $18.04 | N/A |
| Revenue Next Year | $4.36 | N/A |
| P/E Ratio | $9.52 | ★ N/A |
| Revenue Growth | ★ 19.58 | N/A |
| 52 Week Low | $13.34 | $2.88 |
| 52 Week High | $17.69 | $20.37 |
Technical Indicators
Market Signals| Indicator | LCNB | BIOA |
|---|---|---|
| Relative Strength Index (RSI) | 59.17 | 64.40 |
| Support Level | $15.58 | $8.46 |
| Resistance Level | $16.07 | $9.62 |
| Average True Range (ATR) | 0.38 | 0.45 |
| MACD | 0.03 | -0.02 |
| Stochastic Oscillator | 91.23 | 77.23 |
Price Performance
Historical ComparisonAbout LCNB LCNB Corporation
LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.